In the past decade, high-content screening has become a highly developed approach to obtaining richly descriptive quantitative phenotypic data using automated microscopy. From early use in drug screening, the technique has evolved to embrace a diverse range of applications in both academic and industrial sectors and is now widely recognized as providing an efficient and effective approach to large-scale programs investigating cell biology in situ and in context.
Taylor DL: Past, present, and future of high content screening and the field of cellomics . Methods Mol Biol2007;356:3-18.
2.
Lee S., Howell BJ: High-content screening: emerging hardware and software technologies . Methods Enzymol2006;414:468-483.
3.
Yeow K., Nichols A., Lang P., Scheer A.: Cellular imaging in drug discovery. Nat Rev Drug Discov2006;5:343-356.
4.
Zemanová L., Schenk A., Valler MJ, Nienhaus GU, Heilker R.: Confocal optics microscopy for biochemical and cellular high-throughput screening. Drug Discov Today2003;8:1085-1093.
5.
Bowen WP, Wylie PG: Application of laser-scanning fluorescence microplate cytometry in high content screening. Assay Drug Dev Technol2006;4:209-221.
6.
Molecular Devices: MetaMorph® customers . . . it’s your choice!www.moleculardevices.com/pages/software/metamorph.html
7.
Boland MV, Murphy RF: A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics2001;17:1213-1223.
8.
Gough AH, Johnston PA: Requirements, features, and performance of high content screening platforms . Methods Mol Biol2007;356:41-61.
9.
Das AK, Sato M., Story MD, Peyton M., Graves R., Redpath S., et al: Non-small-cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res2006; 66:9601-9608.
10.
Rodriguez RA , Alfonso J., O’Day C., Ovechkina Y., Ward C.: 297 distinct cell lines: a high-content analysis assay and a full-automation design solely using noncontact liquid dispensing. J Assoc Lab Automation2007; 12:318-326.
11.
Gerets HH, Hanon E., Cornet M., Dhalluin S., Depelchin O., Canning M., et al: Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach. Toxicol In Vitro2009;23:319-332.
12.
Wollman R., Stuurman N.: High throughput microscopy: from raw images to discoveries. J Cell Sci2007;120:3715-3722.
13.
Carpenter AE : Extracting rich information from images. Methods Mol Biol2009;486:193-211.
MIACA (Minimum Information About a Cellular Assay): http://miaca.sourceforge.net/
16.
Giuliano KA , Taylor DL, Waggoner AS: Reagents to measure and manipulate cell functions. Methods Mol Biol2007;356:141-163.
17.
Thomas N.: Fluorescent proteins and engineered cell lines. Methods Mol Biol2007;356:165-187.
18.
Ferguson SS , Caron MG: Green fluorescent protein-tagged beta-arrestin translocation as a measure of G protein-coupled receptor activation . Methods Mol Biol2004;237:121-126.
19.
Trask OJ Jr , Baker A. , Williams RG, Nickischer D., Kandasamy R., Laethem C., et al: Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform. Methods Enzymol2006;414:419-439.
20.
Adams CL, Kutsyy V., Coleman DA, Cong G., Crompton AM, Elias KA, et al: Compound classification using image-based cellular phenotypes . Methods Enzymol2006;414:440-468.
21.
Hoffman AF, Garippa RJ: A pharmaceutical company user’s perspective on the potential of high content screening in drug discovery. Methods Mol Biol2007;356:19-31.
22.
Bickle M.: High-content screening: a new primary screening tool?IDrugs2008;11:822-826.
23.
Korn K., Krausz E.: Cell-based high-content screening of small-molecule libraries. Curr Opin Chem Biol2007;11:503-510.
24.
Garippa RJ, Hoffman AF, Gradl G., Kirsch A.: High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera . Methods Enzymol2006;414:99-120.
25.
Lundholt BK , Linde V., Loechel F., Pedersen HC, Møller S., Praestegaard M., et al: Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer . J Biomol Screen2005;10:20-29.
26.
Dove A.: Screening for content: the evolution of high throughput. Nat Biotechnol2003;21:859-864.
27.
Mouchet EH, Simpson PB: High-content assays in oncology drug discovery: opportunities and challenges . IDrugs2008;11:422-427.
28.
Dragunow M. : High-content analysis in neuroscience. Nat Rev Neurosci2008;9:779-788.
29.
O’Brien PJ, Irwin W., Diaz D., Howard-Cofield E., Krejsa CM, Slaughter MR, et al: High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch Toxicol2006;80:580-604.
30.
Low J., Stancato L., Lee J., Sutherland JJ: Prioritizing hits from phenotypic high-content screens. Curr Opin Drug Discov Devel2008;11: 338-345.
31.
Giuliano KA , Chen Y-T., Taylor DL: High content screening with siRNA optimizes a cell biological approach to drug discovery: defining the role of p53 activation in the cellular response to anticancer drugs. J Biomol Screen2004;9:557-568.
32.
Perlman ZE, Slack MD, Feng Y., Mitchison TJ, Wu LF, Altschuler SJ: Multidimensional drug profiling by automated microscopy. Science2004; 306:1194-1198.
33.
Young IT: Proof without prejudice: use of the Kolmogorov-Smirnov test for the analysis of histograms from flow systems and other sources. J Histochem Cytochem1977;25:935-941.
34.
Bin Zhang , Xiubin Gu , Uppalapati U., Ashwell MA, Leggett DS, Li CJ: High-content fluorescent-based assay for screening activators of DNA damage checkpoint pathways. J Biomol Screen2008;13:538-543.
Loo LH, Wu LF, Altschuler SJ: Image-based multivariate profiling of drug responses from single cells. Nat Methods2007;4:445-453.
37.
Wang J., Zhou X., Bradley PL, Chang SF, Perrimon N., Wong ST: Cellular phenotype recognition for high-content RNA interference genome-wide screening. J Biomol Screen2008 ;13:29-39.
38.
Young DW, Bender A., Hoyt J., McWhinnie E., Chirn GW, Tao CY, et al: Integrating high-content screening and ligand-target prediction to identify mechanism of action. Nat Chem Biol2008;4:59-68.
39.
Tanaka M., Bateman R., Rauh D., Vaisberg E., Ramachandani S., Zhang C., et al: An unbiased cell morphology-based screen for new, biologically active small molecules. PLoS Biol2005;3:e128.
40.
Leader B., Baca QJ, Golan DE: Protein therapeutics: a summary and pharmacological classification . Nat Rev Drug Discov2008;7:21-39.
41.
de Fougerolles A., Vornlocher HP, Maraganore J., Lieberman J.: Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov2007;6:443-453.
42.
Davis ME, Chen ZG, Shin DM: Nanoparticle therapeutics: an emerging treatment modality for cancer . Nat Rev Drug Discov2008;7:771-782.
43.
Jensen J., Hyllner J., Björquist P.: Human embryonic stem cell technologies and drug discovery. J Cell Physiol2009;219:513-519.
44.
Steel D., Hyllner J., Sartipy P.: Cardiomyocytes derived from human embryonic stem cells: characteristics and utility for drug discovery. Curr Opin Drug Discov Dev2009;12:133-140.
45.
Webb S.: iPS cell technology gains momentum in drug discovery. Nat Rev Drug Discov2009;8:263-264.
46.
Stubbs S., Thomas N.: Dynamic green fluorescent protein sensors for high-content analysis of the cell cycle. Methods Enzymol2006;414:1-21.
47.
Sakaue-Sawano A., Kurokawa H., Morimura T., Hanyu A., Hama H., Osawa H., et al: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell2008;132:487-498.
48.
Bullen A.: Microscopic imaging techniques for drug discovery. Nat Rev Drug Discov2008;7:54-67.
49.
Battle DJ, Lau CK, Wan L., Deng H., Lotti F., Dreyfuss G.: The Gemin5 protein of the SMN complex identifies snRNAs. Mol Cell2006;23: 273-279.
50.
Caunt CJ, Rivers CA, Conway-Campbell BL, Norman MR, McArdle CA: Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases. J Biol Chem2008;283:6241-6252.
51.
Danzer KM, Haasen D., Karow AR, Moussaud S., Habeck M., Giese A., et al: Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci2007;27:9220-9232.
52.
Finch AR, Sedgley KR, Caunt CJ, McArdle CA: Plasma membrane expression of GnRH receptors: regulation by antagonists in breast, prostate, and gonadotrope cell lines. J Endocrinol2008;196:353-367.
53.
Haasen D., Wolff M., Valler MJ, Heilker R.: Comparison of G-protein coupled receptor desensitization-related β-arrestin redistribution using confocal and non-confocal imaging. Comb Chem High Throughput Screen2006;9:37-47.
54.
Harada H., Takahashi M.: CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J Biol Chem2007 ; 282:5597-5607.
55.
Li F., Zhou X., Zhu J., Ma J., Huang X., Wong STC: High content image analysis for human H4 neuroglioma cells exposed to CuO nanoparticles. BMC Biotechnol2007;7:66.
56.
Mosaliganti K., Chen J., Janoos F., Machiraju T., Xia W., Xu X., et al: Automated quantification of colony growth in clonogenic assays . Paper presented at Medical Image Computing and Computer-Assisted Intervention (MICCAI); October 29 to November 2, 2007; Brisbane, Australia.
57.
Nishino N., Tamori Y., Tateya S., Kawaguchi T., Shibakusa T., Mizunoya W., et al: FSP27 contributes to efficient energy storage in murine white adipocytes by promoting the formation of unilocular lipid droplets. J Clin Invest2008;118:2808-2821.
58.
Park J-Y., Hwang EM, Park N., Kim E., Kim D-G., Kang D., et al: Gateway RFP-fusion vectors for high throughput functional analysis of genes. Mol Cells2007;23:357-362.
59.
Park KM, Kang E., Jeon YJ, Kim N., Kim NS, Yoo HS, et al. Identification of novel regulators of apoptosis using a high-throughput cell-based screen. Mol Cells2007;23:170-174.
60.
Ross S., Chen T., Yu V., Tudor Y., Zhang D., Liu L., et al: High-content screening analysis of the p38 pathway: profiling of structurally related p38α kinase inhibitors using cell-based assays . Assay Drug Dev Technol2006;4:397-409.
61.
Shen H., Zhang Y., Ding H., Wang X., Chen L., Jiang H., et al: Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter cell. Physiol Biochem2008;22(1-4):1-14.
62.
Sun T., Ye F., Ding H., Chen K., Jiang H., Shen X.: Protein tyrosine phosphatase 1B regulates TGFb1-induced Smad2 activation through PI3 kinase-dependent pathway. Cytokine2006 ;35(1-2):88-94.
63.
Sun T., Wang Q., Yu Z., Zhang Y., Guo Y., Chen K., et al: Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFb/ Smad2 signaling. Chembiochem2007;8:187-193.
64.
Verma NK, Dourlat J., Davies AM, Long A., Liu WQ, Garbay C., et al: STAT3-stathmin interactions control microtubule dynamics in migrating T-cells. J Biol Chem2009;284:12349-12362.
65.
Zhang C., Yang N., Yang CH, Ding HS, Luo C., Zhang Y., et al: S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton. PLoS ONE2009;4(3):e4881.
Zhao H., Tang C., Cui K., Ang BT, Wong ST: A screening platform for glioma growth and invasion using bioluminescence imaging. J Neurosurg2009 Feb 6. [Epub ahead of print]
68.
Jan E., Byrne SJ, Cuddihy M., Davies AM, Volkov Y., Gun’ko YK, et al: High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. ACS Nano2008;2:928-938.
69.
Chan GK, Lutterbach BA, Pan BS, Kariv I., Szewczak AA: High-throughput analysis of HGF-stimulated cell scattering. J Biomol Screen2008;13:847.
70.
Santos AF, Zaltsman AB, Martin RC, Kuzmin A., Alexandrov Y., Roquemore EP, et al: Angiogenesis: an improved in vitro biological system and automated image-based workflow to aid identification and characterization of angiogenesis and angiogenic modulators. Assay Drug Dev Technol2008;6:693-710.
71.
Kim D., Chae Y., Kim SJ: High content cellular analysis for functional screening of novel cell cycle related genes. BMEI2008;1(27-30): 148-152.
72.
Liberatore AM, Coulomb H., Pons D., Dutruel O., Kasprzyk PG, Carlson M., et al: IRC-083927 is a new tubulin binder that inhibits growth of human tumor cells resistant to standard tubulin-binding agents. Mol Cancer Ther2008;7:2426-2434.
73.
Li F., Zhou X., Zhu J., Xia W., Ma J., Wong ST: Workflow and methods of high-content time-lapse analysis for quantifying intracellular calcium signals. Neuroinformatics2008;6:97-108.
74.
Fujita Y., Kakino A., Nishimichi N., Yamaguchi S., Sato Y., Machida S., et al: Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects. Clin Chem2009 ;55:285-294.
75.
Kato H., Ishida J., Nagano K., Honjo K., Sugaya T., Takeda N., et al: Deterioration of atherosclerosis in mice lacking angiotensin II type 1A receptor in bone marrow-derived cells. Lab Invest2008;88:731-739.
76.
Antczak C., Kloepping C., Radu C., Genski T., Muller-Kuhrt L., Siems K., et al: Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides. Invest Ophthalmol Vis Sci2009;50:3065-3073.
77.
Prevo R., Deutsch E., Sampson O., Diplexcito J., Cengel K., Harper J., et al: Class I PI3 kinase inhibition by the pyridinylfuranopyrimidine inhibitor PI-103 enhances tumor radiosensitivity. Cancer Res2008;68: 5915-5923.
78.
Chae Y., Kim SJ, Desok Kim D.: Screening of Apoptotic Genes by Morphological Analysis of High Throughput Fluorescence Microscopy Images. Jeju Island, Korea: FBIT, 2007.
